AtriCure, Inc. (ATRC) stock
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.45+0.43 (+0.78%)
Close on Nov 18, 2026Market cap $2.82BP/E 264.0Yield –
AtriCure operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
AtriCure's operating income for the twelve months ending Jun 30, 2026 was $12.89M. For fiscal 2025 it was -$9.45M. The highest annual figure on record is $55.21M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.45M | – |
| FY2024 | Dec 31, 2024 | -$40.01M | – |
| FY2023 | Dec 31, 2023 | -$26.68M | – |
| FY2022 | Dec 31, 2022 | -$42.67M | -177.3% |
| FY2021 | Dec 31, 2021 | $55.21M | – |
| FY2020 | Dec 31, 2020 | -$44.23M | – |
| FY2019 | Dec 31, 2019 | -$33.12M | – |
| FY2018 | Dec 31, 2018 | -$17.13M | – |
| FY2017 | Dec 31, 2017 | -$24.98M | – |
| FY2016 | Dec 31, 2016 | -$31.14M | – |
| FY2015 | Dec 31, 2015 | -$26.72M | – |
| FY2014 | Dec 31, 2014 | -$16.36M | – |
| FY2013 | Dec 31, 2013 | -$10.89M | – |
| FY2012 | Dec 31, 2012 | -$7.20M | – |
| FY2011 | Dec 31, 2011 | -$4.73M | – |
| FY2010 | Dec 31, 2010 | -$3.19M | – |
| FY2009 | Dec 31, 2009 | -$15.51M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.67M | – |
| Q1 FY2026 | Mar 31, 2026 | $526.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $2.49M | – |
| Q3 FY2025 | Sep 30, 2025 | $208.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.19M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.95M | – |
| Q4 FY2024 | Dec 31, 2024 | -$14.52M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.41M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.17M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.92M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.67M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.09M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.14M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.78M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.14M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.72M | -110.9% |
| Q2 FY2022 | Jun 30, 2022 | -$13.66M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.15M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.50M | – |
| Q3 FY2021 | Sep 30, 2021 | $98.67M | – |
| Q2 FY2021 | Jun 30, 2021 | -$15.08M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.89M | – |
| Q4 FY2020 | Dec 31, 2020 | -$17.50M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.99M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.29M | – |
| Q1 FY2020 | Mar 31, 2020 | -$15.45M | – |
| Q4 FY2019 | Dec 31, 2019 | -$15.33M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.64M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.84M | -500.7% |
| Q1 FY2019 | Mar 31, 2019 | -$5.32M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.61M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.05M | – |
| Q2 FY2018 | Jun 30, 2018 | $958.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$9.43M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.14M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.85M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.36M | – |
| Q1 FY2017 | Mar 31, 2017 | -$9.64M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.70M | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.29M | – |
See a number that looks wrong?